-
公开(公告)号:US20240294942A1
公开(公告)日:2024-09-05
申请号:US18667718
申请日:2024-05-17
发明人: Kepler MEARS , Robert MANGUSO , Kathleen YATES
IPC分类号: C12N15/86 , A61K48/00 , C07K14/005 , C07K16/28
CPC分类号: C12N15/86 , A61K48/0058 , C07K14/005 , C07K16/2803 , C07K16/2812 , C07K16/2815 , C07K16/2833 , C07K16/289 , C07K2317/569 , C07K2317/622 , C07K2319/33 , C12N2740/15042 , C12N2740/15045 , C12N2740/15052 , C12N2740/15062 , C12N2740/15071 , C12N2760/18422 , C12N2760/18471
摘要: The invention features pseudotyped viral particles (e.g., lentiviral or gammaretroviral particles) and compositions and methods of use thereof, where the viral particles comprise a VHH domain.
-
2.
公开(公告)号:US20240261389A1
公开(公告)日:2024-08-08
申请号:US18561154
申请日:2022-05-15
发明人: Linfa Wang , Wan Ni Chia , Chee Wah Tan , Feng Zhu
IPC分类号: A61K39/215 , A61K39/00 , A61P31/14 , C07K14/005 , C12N7/00 , C12N15/86
CPC分类号: A61K39/215 , A61P31/14 , C07K14/005 , C12N7/00 , C12N15/86 , A61K2039/53 , A61K2039/55566 , A61K2039/55572 , C12N2710/24022 , C12N2710/24043 , C12N2750/14122 , C12N2750/14143 , C12N2760/18422 , C12N2760/18443 , C12N2760/20222 , C12N2760/20243 , C12N2770/20034
摘要: Disclosed herein is a method of making an amino acid construct for the treatment and/or prevention of sarbecovirus infections, comprising: a. comparing amino acid sequences from at least two different sarbecovirus spike proteins or fragments thereof; b. identifying identical amino acids in the sequences from the at least two different sarbecovirus spike proteins or fragments thereof; c. removing any different amino acids from the sequences of the at least two different sarbecovirus spike proteins or fragments thereof to identify a unique amino acid sequence; and d. forming the amino acid construct of the unique amino acid sequence wherein the amino acid construct has at least 90% sequence identity to the at least two different sarbecovirus spike proteins or fragments thereof. Also disclosed are amino acid sequences generated using the method of the invention.
-
公开(公告)号:US12018273B2
公开(公告)日:2024-06-25
申请号:US17465734
申请日:2021-09-02
发明人: Thomas Schaser , Andrew Kaiser , Laura Kapitza , Jessica Hartmann , Frederic Thalheimer , Christian Buchholz
IPC分类号: C12N15/867 , C07K14/005 , C07K14/01 , C07K16/28 , C12N5/0783 , C12N7/00 , C12N15/86
CPC分类号: C12N15/86 , C07K14/005 , C07K16/2854 , C12N5/0636 , C12N7/00 , C07K2317/622 , C07K2319/21 , C07K2319/30 , C12N2740/10043 , C12N2760/18422
摘要: The present invention provides a composition comprising i) a pseudotyped retroviral vector particle comprising a) one envelope protein with antigen-binding activity, wherein said envelope protein is a recombinant protein that does not interact with at least one of its original receptors and is fused at its ectodomain to a polypeptide comprising an antigen binding domain specific for CD62L, and wherein said envelope protein is protein G, HN or H derived from the Paramyxoviridae family, b) one envelope protein with fusion activity derived from the Paramyxoviridae family, and T cells expressing CD62L. Alternatively, when said polypeptide comprising an antigen binding domain is specific for a tag of a tagged polypeptide instead of the antigen binding domain specific for CD62L, wherein said tagged polypeptide binds specifically to CD62L, then the composition comprises further said tagged polypeptide.
-
4.
公开(公告)号:US20240139306A1
公开(公告)日:2024-05-02
申请号:US18279314
申请日:2022-03-01
发明人: Ganwu Li , Bailey Arruda , Huigang Shen , Ying Zheng
IPC分类号: A61K39/155 , C07K16/10 , C12N7/00 , G01N33/569 , G01N33/58 , A61K39/00
CPC分类号: A61K39/155 , C07K16/1027 , C12N7/00 , G01N33/56983 , G01N33/581 , A61K2039/552 , C12N2760/18422 , C12N2760/18434 , C12N2760/18451 , G01N2333/115
摘要: Disclosed herein are methods for detecting and producing PoMV. Further, disclosed herein are immunogenic and/or vaccine compositions and methods for treating or preventing PoMV. The compositions and methods include immunogenic portions of PoMV including entry proteins. In at least particular cases, a mutated version of a portion of the PoMV is utilized, such as a deglycosylated, or amino acid substituted mutant of the spike protein.
-
公开(公告)号:US20240093233A1
公开(公告)日:2024-03-21
申请号:US18261051
申请日:2022-01-13
申请人: VIROXIS , INSTITUT PASTEUR , CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE , INSTITUT GUSTAVE ROUSSY (IGR)
发明人: Thierry HEIDMANN , Frederic TANGY
CPC分类号: C12N15/86 , A61P31/18 , C07K14/15 , C12N7/00 , C12N2740/16122 , C12N2760/18422 , C12N2760/18443 , C12N2770/24122
摘要: The invention relates to recombinant measles virus expressing Immunodeficiency virus (IV) or HTLV polypeptides, and concerns in particular immunogenic immunodeficiency virus particles expressed by a measles virus and/or virus like particles (VLPs) that contain proteins of at least one immunodeficiency virus or Human T-lymphotropic virus. These particles may be recombinant infectious particles able to replicate in a host after an administration. The invention provides means, in particular nucleic acid constructs, vectors, cells and rescue systems to produce these recombinant infectious particles. The invention also relates to the use of these recombinant infectious particles, in particular under the form of a composition, more particularly in a vaccine formulation, for the treatment or prevention of an infection by HIV or HTLV.
-
公开(公告)号:US20180214497A1
公开(公告)日:2018-08-02
申请号:US15864217
申请日:2018-01-08
IPC分类号: A61K35/766 , C12N15/86 , C12N7/00 , C07K14/005
CPC分类号: A61K35/766 , A61K38/00 , C07K14/005 , C12N7/00 , C12N15/86 , C12N2760/18422 , C12N2760/20221 , C12N2760/20222 , C12N2760/20232 , C12N2760/20271 , C12N2810/6081 , C12N2810/859
摘要: This document provides methods and materials related to vesicular stomatitis viruses. For example, replication-competent vesicular stomatitis viruses, nucleic acid molecules encoding replication-competent vesicular stomatitis viruses, methods for making replication-competent vesicular stomatitis viruses, and methods for using replication-competent vesicular stomatitis viruses to treat cancer or infectious diseases are provided.
-
公开(公告)号:US20180104320A1
公开(公告)日:2018-04-19
申请号:US15568491
申请日:2016-04-26
发明人: Claudia Gravekamp
IPC分类号: A61K39/00 , C07K14/33 , A61K35/74 , A61K39/39 , A61K45/00 , C07K14/105 , C07K14/12 , C12N1/36
CPC分类号: A61K39/0011 , A61K35/74 , A61K39/08 , A61K39/39 , A61K45/05 , A61K2039/5154 , A61K2039/522 , A61K2039/585 , A61P35/04 , C07K14/005 , C07K14/105 , C07K14/12 , C07K14/33 , C12N1/36 , C12N2760/18422 , C12N2760/18433 , C12N2770/32622 , C12N2770/32633 , Y02A50/466 , Y02A50/471
摘要: Methods, pharmaceutical compositions and vaccines comprising an attenuated bacteria that expresses a recall antigen are disclosed for treatment of cancer.
-
公开(公告)号:US09555067B2
公开(公告)日:2017-01-31
申请号:US14395388
申请日:2013-03-13
IPC分类号: A61K35/76 , A61K35/766 , C07K14/005 , C12N7/00 , A61K38/00
CPC分类号: A61K35/766 , A61K38/00 , C07K14/005 , C12N7/00 , C12N15/86 , C12N2760/18422 , C12N2760/20221 , C12N2760/20222 , C12N2760/20232 , C12N2760/20271 , C12N2810/6081 , C12N2810/859
摘要: This document provides methods and materials related to vesicular stomatitis viruses. For example, replication-competent vesicular stomatitis viruses, nucleic acid molecules encoding replication-competent vesicular stomatitis viruses, methods for making replication-competent vesicular stomatitis viruses, and methods for using replication-competent vesicular stomatitis viruses to treat cancer or infectious diseases are provided.
摘要翻译: 本文件提供了与水泡性口炎病毒相关的方法和材料。 例如,提供了可复制的水泡性口炎病毒,编码可复制的水泡性口炎病毒的核酸分子,用于制备具有复制能力的水泡性口炎病毒的方法,以及使用可复制的水泡性口炎病毒治疗癌症或感染性疾病的方法。
-
公开(公告)号:US20160103130A1
公开(公告)日:2016-04-14
申请号:US14881728
申请日:2015-10-13
发明人: Shmuel ARIAD , Jacob GOPAS , Daniel BENHARROCH , Irina LAZAREV
IPC分类号: G01N33/574 , A61N5/10 , A61K45/06 , A61K39/165 , C12N7/00
CPC分类号: G01N33/57423 , A61K39/165 , A61K45/06 , A61K2039/525 , A61K2039/53 , A61K2039/54 , A61K2039/57 , A61K2039/585 , A61N5/10 , C07K14/005 , C12N7/00 , C12N2760/18422 , C12N2760/18432 , C12N2760/18434 , G01N1/30 , G01N33/57415 , G01N2333/12 , G01N2800/52
摘要: The present invention provides methods for treating specific populations of cancer patients by immunotherapy. The methods comprise administering an immunogenic composition eliciting an immune response to measles virus to patients having measles virus-immunoreactive cancer cells.
摘要翻译: 本发明提供了通过免疫治疗来治疗癌症患者的特定群体的方法。 所述方法包括向具有麻疹病毒免疫反应性癌细胞的患者施用引发针对麻疹病毒的免疫应答的免疫原性组合物。
-
公开(公告)号:US09074223B2
公开(公告)日:2015-07-07
申请号:US13520921
申请日:2011-01-07
CPC分类号: C12N15/867 , C07K16/00 , C07K2317/14 , C12N15/86 , C12N2740/16043 , C12N2740/16045 , C12N2760/18422 , C12N2810/6072
摘要: The present disclosure provides compositions and methods for transducing B cells. In particular, the present disclosure provides for vectors and methods for transducing resting B cells and methods for differentiating same to express a transgene of interest.
摘要翻译: 本公开提供用于转导B细胞的组合物和方法。 特别地,本公开内容提供用于转导静息B细胞的载体和方法以及用于分化其的方法以表达感兴趣的转基因。
-
-
-
-
-
-
-
-
-